Article
Neutralization of SARS-CoV-2 by Destruction of the Prefusion Spike
2020-06-01
Abstract excerpt
There are as yet no licenced therapeutics for the COVID-19 pandemic. The causal coronavirus (SARS-CoV-2) binds host cells via a trimeric Spike whose receptor binding domain (RBD) recognizes angiotensin-converting enzyme 2 (ACE2), initiating conformational changes that drive membrane fusion. We find that monoclonal antibody CR3022 binds the RBD tightly, neutralising SARS-CoV-2 and report the crystal structure at 2....
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 90f48036-1aad-5906-b4d0-35774bd2d8cf
- DOI
- 10.2139/ssrn.3613273
